Nasdaq-listed NewGen to acquire 600,000 SOL

NewGenIvf Group Limited, a Nasdaq-listed infertility treatment services company, has signed an agreement with White Lion Capital to acquire 600,000 SOL, according to a GlobeNewswire press release. Under the agreement, NewGen will have the option to sell its common stock to White Lion over the next 24 months and will receive payment in Solana (SOL) instead of cash. The company currently holds 13,000 SOL.